Treatment of Inflammatory Bowel Disease with Biologics

(C. Jardin) #1

76


been definitively established as superior to either agent alone. Thus, while signifi-
cant inroads have been made in the understanding and treatment of postoperative
CD recurrence, there are many avenues for further exploration to help address this
frequent entity.


References


  1. Lennard-Jones JE, Stalder GA.  Prognosis after resection of chronic regional ileitis. Gut.
    1967;8(4):332–6.

  2. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn’s disease after ileocolic resection:
    endoscopically visualised ileal ulcers preceding symptoms. Gut. 1992;33(3):331–5.

  3. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the
    postoperative course of Crohn’s disease. Gastroenterology. 1990;99(4):956–63.

  4. Sachar DB. The problem of postoperative recurrence of Crohn’s disease. Med Clin North Am.
    1990;74(1):183–8.

  5. Frolkis AD, Dykeman J, Negron ME, Debruyn J, Jette N, Fiest KM, et al. Risk of surgery for
    inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis
    of population-based studies. Gastroenterology. 2013;145(5):996–1006.

  6. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural
    history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut.
    1984;25(6):665–72.

  7. Regueiro M, Kip KE, Schraut W, Baidoo L, Sepulveda AR, Pesci M, et  al. Crohn’s disease
    activity index does not correlate with endoscopic recurrence one year after ileocolonic resec-
    tion. Inflamm Bowel Dis. 2011;17(1):118–26.

  8. Blum E, Katz JA.  Postoperative therapy for Crohn’s disease. Inflamm Bowel Dis.
    2009;15(3):463–72.

  9. Katz JA. Postoperative endoscopic surveillance in Crohn’s disease: bottom up or top down?
    Gastrointest Endosc. 2007;66(3):541–3.

  10. Daperno M, Comberlato M, Bossa F, Biancone L, Bonanomi AG, Cassinotti A, et  al.
    Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing
    study from the Italian Group for Inflammatory Bowel Disease (IG-IBD). Dig Liver Dis.
    2014;46(11):969–73.

  11. Marteau P, Laharie D, Colombel JF, Martin L, Coevoet H, Allez M, et al. Interobserver varia-
    tion study of the rutgeerts score to assess endoscopic recurrence after surgery for Crohn’s
    disease. J Crohns Colitis. 2016;10(9):1001–5.

  12. Lasson A, Strid H, Ohman L, Isaksson S, Olsson M, Rydstrom B, et al. Fecal calprotectin one
    year after ileocaecal resection for Crohn’s disease – a comparison with findings at ileocolonos-
    copy. J Crohns Colitis. 2014;8(8):789–95.

  13. Boschetti G, Laidet M, Moussata D, Stefanescu C, Roblin X, Phelip G, et al. Levels of fecal
    calprotectin are associated with the severity of postoperative endoscopic recurrence in asymp-
    tomatic patients with Crohn’s disease. Am J Gastroenterol. 2015;110(6):865–72.

  14. Qiu Y, Mao R, Chen BL, He Y, Zeng ZR, Xue L, et al. Fecal calprotectin for evaluating postop-
    erative recurrence of Crohn’s disease: a meta-analysis of prospective studies. Inflamm Bowel
    Dis. 2015;21(2):315–22.

  15. Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Krejany EO, et al. Measurement
    of fecal calprotectin improves monitoring and detection of recurrence of Crohn’s disease after
    surgery. Gastroenterology. 2015;148(5):938–47.e1.

  16. DiCandio G, Mosca F, Campatelli A, Bianchini M, D’Elia F, Dellagiovampaola
    C. Sonographic detection of postsurgical recurrence of Crohn disease. AJR Am J Roentgenol.
    1986;146(3):523–6.


B.H. Click and M. Regueiro
Free download pdf